Sparian Biosciences Awarded $19 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development
Sparian Biosciences, Inc., a clinical-stage CNS-focused biopharmaceutical company, announced it has been awarded a $19 million, five-year grant to fund the development of SBS-518 from IND submission through Phase 1 clinical development.
Newly Discovered Probiotic Could Protect Caribbean Corals Threatened by Deadly, Devastating Disease
Researchers with the Smithsonian’s National Museum of Natural History and the University of Florida have discovered the first effective bacterial probiotic for treating and preventing stony coral tissue loss disease, or SCTLD, a mysterious ailment that has devastated Florida’s coral reefs since 2014 and is rapidly spreading throughout the Caribbean.
Targeting a Human Protein To Squash SARS-CoV-2 and Other Viruses
More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies. In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
UF College of Pharmacy Moves Into Top 3 of National Research Rankings
The University of Florida College of Pharmacy moved up two places to No. 3 in the nation for total research funding in the latest American Association of Colleges of Pharmacy, or AACP, report released June 23. The No. 3 ranking is the highest ever achieved by the college when compared to peer institutions
Three UF Faculty Elected to Academy of Science, Engineering, and Medicine of Florida
Three University of Florida faculty will be inducted into the Academy of Science, Engineering, and Medicine of Florida in 2022. The academy, which recognizes the work of individuals of the State of Florida who have made major achievements in science, engineering, and medicine, will present awards to the following faculty during its annual meeting on November 5-6 in Orlando.
New Medicinal Plants Course Addresses Industry Needs
Emerging industries require a skilled workforce to function. Sometimes, the industry begins to boom before employers can hire a sufficient number of skilled employees. That was the case for many employers in the medicinal plant industry, which includes crops like hemp, kava and kratom. Faculty from two University of Florida colleges worked together to help meet that demand with a new course.
UF College of Pharmacy, American Pharmacists Association To Offer Test-and-Treat Certificate Program
The University of Florida College of Pharmacy and the American Pharmacists Association, or APhA, announced a new partnership today that will allow pharmacists to test patients for several non-emergency health issues.
Discovery of Dual-Degrading Compound Could Pave Way for More Effective Cancer Drugs
University of Florida researchers have developed a new compound that simultaneously attacks two key proteins critical for a cancer cell’s survival, a discovery that could aid in the development of more effective leukemia, lung and colon cancer drugs.
Dean Julie Johnson Presented 2021 Precision Medicine World Conference Luminary Award
Julie Johnson, Pharm.D., dean and distinguished professor in the University of Florida College of Pharmacy, was presented the 2021 Precision Medicine World Conference, or PMWC, Luminary Award on Sept. 23, 2021 in Pittsburgh.
New AI Tool Will Predict Patients at High Risk for Opioid Use Disorder and Overdose
University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose.
